BMS Says Genetic Technologies' DNA Tech Is Unpatentable
Bristol-Myers Squibb Co. on Tuesday urged a Delaware federal court to dismiss Australian company Genetic Technologies Ltd.'s suit accusing it of infringing patents relating to DNA technology, arguing the patents cover...To view the full article, register now.
Already a subscriber? Click here to view full article